GAMBARAN FUNGSI HATI PASIEN DIABETES MELITUS TIPE II DI SALAH SATU RUMAH SAKIT SWASTA DI KABUPATEN DEMAK PERIODE OKTOBER-DESEMBER 2020

  • Megi Pangestuningsih Politeknik Katolik Mangun Wijaya
  • Fef Rukminingsih Politeknik Katolik Mangun Wijaya
Keywords: Liver Fungtion, DM Type II, Oral Antidiabetic Agent

Abstract

            Type II DM patients use Oral Antidiabetic Agent (OAA) continuously for a long time. OAA metabolism occurs in the liver. The use of OAA continuously in the long term can cause liver function disorders. The purpose of this study was to describe the liver function of type II DM patients who were treated with OAA in a private hospital in Demak District. This study is an observational descriptive study using retrospective data obtained from medical record documents of outpatients with type II DM for the period October – December 2020. Sampling using purposive sampling technique. The inclusion criteria were outpatients with type II DM, JKN participants who received OAA therapy for at least one year, aged 36 – 65 years old, have AST and ALT laboratory examinations. Patients who received combination therapy with insulin, had a history of impaired liver function were excluded. The results showed that from 62 patients there were 39 female patients (62.9%), the most patients aged 56-65 years were 32 patients (51.61%). The longest duration of use of OAA was 1 year, namely 29 patients (46.77%). The most widely used OAA was a combination of biguanides and sulfonylureas in 36 patients (58.07%). A total of 51 patients (82.25%) did not experience liver function damage and as many as 11 patients (17.75%) showed mild liver function damage with the duration of using OHO for more than 1 year and using OHO combination.

Downloads

Download data is not yet available.

References

Arifin L. Augusta. PANDUAN TERAPI DIABETES MELLITUS TIPE 2 TERKINI. Fakultas Kedokteran UNPAD/ RSUP dr. Hasan Sadikin. Diakses dari :
http://pustaka.unpad.ac.id/wp-content/uploads/2011/03/panduan_terapi_diabetes_mellitus.pdf

Ayele K, Tesfa B, Abebe L, Tilahun T, Girma E (2012) SELF CARE BEHAVIOR AMONG PATIENTS WITH DIABETES IN HARARI, EASTERN ETHIOPIA: THE HEALTH BELIEF MODEL PERSPECTIVE. PLOS ONE 7(4): e35515. https://doi.org/10.1371/journal.pone.0035515

Fanani, A. 2020. HUBUNGAN FAKTOR RISIKO DENGAN KEJADIAN DIABETES MELLITUS. Jurnal Keperawatan, Vol. 12 (3), hal. 371-378

Isnaini, N., & Ratnasari, R. (2018). FAKTOR RISIKO MEMPENGARUHI KEJADIAN DIABETES MELLITUS TIPE DUA. Jurnal Kebidanan Dan Keperawatan Aisyiyah, 14(1), 59–68. https://doi.org/10.31101/jkk.550

Kemenkes RI. (2013). Peraturan Menteri Kesehatan Republik Indonesia Nomor 71 Tahun 2013 Tentang Pelayanan Kesehatan Pada Jaminan Kesehatan Nasional. Kementerian Kesehatan Republik Indonesia.

Kemenkes RI. (2018). Hasil Utama Riskesdas Tentang Prevalensi Diabetes Mellitus di Indonesia 2018. Kementerian Kesehatan Republik Indonesia

Komariah & Rahayu, S. (2020). HUBUNGAN USIA, JENIS KELAMIN DAN INDEKS MASSA TUBUH DENGAN KADAR GULA DARAH PUASA PADA PASIEN DIABETES MELITUS TIPE 2 DI KLINIK PRATAMA RAWAT JALAN PROKLAMASI DEPOK JAWA BARAT. Jurnal Kesehatan Kusuma Husada, 11(1), 41-50. https://doi.org/10.34035/jk.v11i1.412

Kovy, M. (2019). EVALUASI PENGGUNAAN OBAT ANTIDIABETES ORAL PADA PASIEN DIABETES MELITUS TIPE II RAWAT JALAN DI RSUD PROF. DR. SOEKANDAR TAHUN 2016. Journal of Chemical Information and Modeling, 53(9), 1689–1699.

Ndraha, S., Tendean, M., Wician, F., Tan, HT., Yap, H. (2013), LIVER DISORDERS IN TYPE 2 DIABETES MELLITUS. The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 14(3), 154-157.

Nuryati. (2017). Farmakologi. Kementerian Kesehatan Republik Indonesia. Jakarta

Rukminingsih, F., & Widiastuti, M. (2021). LAJU FILTRASI GLOMERULUS PASIEN DIABETES MELITUS TIPE II DI SALAH SATU RUMAH SAKIT SWASTA DI KABUPATEN DEMAK. Jurnal Riset Kefarmasian Indonesia, 3(3), 152-161. https://doi.org/10.33759/jrki.v3i3.179

Saudo, R. M., Rampengan, N. H., & Mandei, J. M. (2016). GAMBARAN HASIL PEMERIKSAAN FUNGSI HATI PADA ANAK DENGAN INFEKSI DENGUE PERIODE JANUARI 2011-OKTOBER 2016 DI RSUP PROF. DR. R. D. KANDOU MANADO. E-CliniC, 4(2), 1-6. https://doi.org/10.35790/ecl.4.2.2016.14476

Siregar, J. (2019). PERBANDINGAN PROFIL LIPID DENGAN HIPERTENSI PADA DIABETES MELLITUSTIPE II DENGAN ATAU TANPA HIPERTENSI DI RS H. ADAM MALIK, MEDAN, INDONESIA. Intisari Sains Medis, 10(2), 354-358. https://doi.org/10.15562/ism.v10i2.376

Suyanto, & Susanto, A. (2016). FAKTOR-FAKTOR YANG BERHUBUNGAN DENGAN KEJADIAN NEUROPATI PERIFER DIABETIK. Jurnal Keperawatan dan Pemikiran Ilmiah, 2(6), 1–7.

Triastuti, N., Irawati, D. N., Levani, Y., & Lestari, R. D. (2020). FAKTOR YANG MEMPENGARUHI TINGKAT KEPATUHAN KONSUMSI OBAT ANTIDIABETES ORAL PADA PASIEN DIABETES MELITUSTIPE II DI RSUD KABUPATEN JOMBANG. Medica Arteriana (Med-Art). 2(1), 27-37. https://doi.org/10.26714/medart.2.1.2020.27-37
Published
2022-05-31
How to Cite
Pangestuningsih, M., & Rukminingsih, F. (2022). GAMBARAN FUNGSI HATI PASIEN DIABETES MELITUS TIPE II DI SALAH SATU RUMAH SAKIT SWASTA DI KABUPATEN DEMAK PERIODE OKTOBER-DESEMBER 2020. Jurnal Riset Kefarmasian Indonesia, 4(2), 134-143. https://doi.org/10.33759/jrki.v4i2.262
Views Statistic
  • Abstract 251
  • PDF 230